Hepatitis B Vaccine (Recombinant) Completed Phase 2 Trials for Plasmodium Infections Prevention

clinicaltrials.gov IdentifierTitleDrugs
NCT00197028Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Region
NCT00289185Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
NCT01231503Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants